Megakaryocyte production is sustained by direct differentiation from erythromyeloid progenitors in the yolk sac until midgestation.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
13 07 2021
Historique:
received: 03 11 2020
revised: 23 02 2021
accepted: 28 04 2021
pubmed: 2 6 2021
medline: 15 9 2021
entrez: 1 6 2021
Statut: ppublish

Résumé

The extra-embryonic yolk sac contains the first definitive multipotent hematopoietic cells, denominated erythromyeloid progenitors. They originate in situ prior to the emergence of hematopoietic stem cells and give rise to erythroid, monocytes, granulocytes, mast cells and macrophages, the latter in a Myb transcription factor-independent manner. We uncovered here the heterogeneity of yolk sac erythromyeloid progenitors, at the single cell level, and discriminated multipotent from committed progenitors, prior to fetal liver colonization. We identified two temporally distinct megakaryocyte differentiation pathways. The first occurs in the yolk sac, bypasses intermediate bipotent megakaryocyte-erythroid progenitors and, similar to the differentiation of macrophages, is Myb-independent. By contrast, the second originates later, from Myb-dependent bipotent progenitors expressing Csf2rb and colonize the fetal liver, where they give rise to megakaryocytes and to large numbers of erythrocytes. Understanding megakaryocyte development is crucial as they play key functions during vascular development, in particular in separating blood and lymphatic networks.

Identifiants

pubmed: 34062116
pii: S1074-7613(21)00188-6
doi: 10.1016/j.immuni.2021.04.026
pmc: PMC8284597
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1433-1446.e5

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Stem Cells. 2016 Feb;34(2):431-44
pubmed: 26418893
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33566111
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Immunity. 2018 Jun 19;48(6):1160-1171.e5
pubmed: 29858009
Int J Biochem Cell Biol. 1999 Oct;31(10):1011-5
pubmed: 10582335
Sci Rep. 2017 Mar 08;7:43817
pubmed: 28272478
Immunity. 2018 Oct 16;49(4):640-653.e5
pubmed: 30332630
Nat Commun. 2018 Jan 8;9(1):75
pubmed: 29311541
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Curr Biol. 1999 Jul 29-Aug 12;9(15):833-6
pubmed: 10469571
Blood. 2021 Feb 25;137(8):1024-1036
pubmed: 33025012
Cell Stem Cell. 2010 Apr 2;6(4):361-8
pubmed: 20362540
Immunity. 2015 Apr 21;42(4):665-78
pubmed: 25902481
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
BMC Genomics. 2018 Jun 19;19(1):477
pubmed: 29914354
Am J Pathol. 2010 Feb;176(2):952-67
pubmed: 20042677
Cell Stem Cell. 2011 Dec 2;9(6):541-52
pubmed: 22136929
Science. 1994 Sep 9;265(5178):1573-7
pubmed: 8079170
J Exp Med. 1999 Jul 5;190(1):43-52
pubmed: 10429669
Nat Protoc. 2019 Jun;14(6):1841-1862
pubmed: 31101904
Blood. 1980 Jan;55(1):138-47
pubmed: 6965346
Nature. 2007 Apr 26;446(7139):1056-61
pubmed: 17377529
Nature. 2000 Mar 9;404(6774):193-7
pubmed: 10724173
Development. 2012 Oct;139(19):3521-30
pubmed: 22899849
Blood. 2008 Mar 1;111(5):2636-9
pubmed: 18174377
Cell. 2008 Feb 22;132(4):631-44
pubmed: 18295580
Nature. 2016 Jul 13;535(7611):299-302
pubmed: 27411635
Blood. 2000 Apr 15;95(8):2543-51
pubmed: 10753833
Cell Rep. 2015 Jun 30;11(12):1892-904
pubmed: 26095363
Development. 1999 Nov;126(22):5073-84
pubmed: 10529424
Nature. 1991 Jan 17;349(6306):257-60
pubmed: 1987478
Blood. 2000 Oct 15;96(8):2641-8
pubmed: 11023493
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Blood. 2004 Nov 15;104(10):3097-105
pubmed: 15251982
Oncogene. 2000 Jul 13;19(30):3335-42
pubmed: 10918590
F1000Res. 2016 Aug 31;5:2122
pubmed: 27909575
Sci Immunol. 2019 May 24;4(35):
pubmed: 31126997
Blood. 1996 Aug 15;88(4):1284-96
pubmed: 8695846
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
Science. 2014 Feb 14;343(6172):776-9
pubmed: 24531970
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):134-9
pubmed: 15623562
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Leukoc Biol. 1989 Feb;45(2):87-96
pubmed: 2536795
J Leukoc Biol. 1996 Feb;59(2):133-8
pubmed: 8603984
Nature. 2015 Feb 26;518(7540):547-51
pubmed: 25470051
Cell. 1991 May 17;65(4):677-89
pubmed: 1709592

Auteurs

Lorea Iturri (L)

Institut Pasteur, Macrophages and endothelial cells, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, 75015 Paris, France; Sorbonne Université, Collège Doctoral, 75005 Paris, France.

Laina Freyer (L)

Institut Pasteur, Macrophages and endothelial cells, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, 75015 Paris, France.

Anne Biton (A)

Institut Pasteur, Bioinformatics and Biostatistics Hub (C3BI), Paris, France.

Pascal Dardenne (P)

Institut Pasteur, Macrophages and endothelial cells, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, 75015 Paris, France.

Yvan Lallemand (Y)

Institut Pasteur, Macrophages and endothelial cells, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, 75015 Paris, France.

Elisa Gomez Perdiguero (E)

Institut Pasteur, Macrophages and endothelial cells, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, 75015 Paris, France. Electronic address: elisa.gomez-perdiguero@pasteur.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH